Nature's Intelligence × Our Connection
Psilocybin
The Mycelium. The Network. The Living Mind.
The network is not beneath you.
You are a node inside it.
European Roots · Psilocin Pharmacology · Clinical Evidence · Living Traditions
The chemistry
was always in your soil.
There is a small, pale mushroom — Psilocybe semilanceata, the liberty cap — that grows in the unfertilized grasslands of Britain, Scandinavia, the Iberian Peninsula, the meadows of Central Europe. It has always grown there. It fruited in the fields where your ancestors kept their animals. It appeared at the edges where children played. The mycological record confirms what folk memory preserved in fragments: Europeans were not ignorant of the mushroom's properties. They were forbidden to name what they knew.
At Selva Pascuala in eastern Spain, a post-Paleolithic mural — among the oldest on the continent — depicts a sequence of fungoid figures alongside a bull. Mycological analysis identifies the forms as resembling Psilocybe hispanica, a locally native neurotropic species. This is not myth. This is archaeology. The earliest direct indicator of probable ritual psilocybin use on European soil. Across Finno-Ugric and Sami territory, Amanita muscaria was used in explicitly shamanic contexts — to enter trance, to contact the dead, to travel cosmological layers — with practices documented by ethnographers that persisted into the twentieth century. Medieval German records name Narrenschwamm, fool's mushrooms, in love potions and vision accounts. Welsh folklore carries Bwyd Ellyon. The Baltic preserves fly agaric in seasonal ceremony. None of this is coincidence. It is a pattern.
And at Eleusis near Athens, for nearly 2,000 years, the most celebrated initiation rite in the ancient world sent the best minds of Greece — Plato, Cicero, Sophocles — into a dark chamber with a drink called kykeon. They entered. They were changed. Cicero wrote that those initiated at Eleusis learned not only how to live with joy, but how to die without fear. Albert Hofmann, Gordon Wasson, and classicist Carl Ruck proposed in 1978 that kykeon was pharmacologically active — ergot-contaminated barley, lysergic alkaloids. Brian Muraresku's The Immortality Key (2020) brought archaeochemical evidence: a ritual chalice from a Greek sanctuary in Spain testing positive for ergotized beer. The suppression was not ignorance. It was policy.
How psilocin rewires the mind
Psilocybin is not itself psychoactive. It is a prodrug — a phosphorylated ester of psilocin (4-hydroxy-DMT). Within minutes of ingestion, alkaline phosphatases in the gut and liver dephosphorylate psilocybin to its active form: psilocin (4-HO-DMT).
Psilocin is a partial agonist at serotonin 5-HT2A receptors, particularly dense in layer V pyramidal neurons of the prefrontal cortex — the region governing executive function, self-referential processing, and emotional regulation. This binding initiates a cascade that transiently disrupts the default mode network (DMN), the brain's "self" architecture.
Simultaneously, psilocin increases glutamate release in the frontal cortex and triggers neuroplasticity: within 24 hours of a single dose, studies demonstrate rapid dendritic spine growth — structural synaptic rewiring visible under electron microscopy. This may underlie the durability of therapeutic effects months after a single session.
What the brain looks like
during dissolution
Functional neuroimaging has made psilocybin one of the best-characterised psychedelic compounds. The findings reveal a brain radically different from both the baseline waking state and sleep — a brain in what Robin Carhart-Harris termed a state of elevated neural entropy: less predictable, more integrated, more plastic.
A trial record
unlike any antidepressant
Psilocybin has now accumulated the largest body of rigorous evidence of any classic psychedelic. A 2022 meta-analysis of 13 randomised controlled trials found significant effects on depression, anxiety, and substance use — with a safety profile superior to SSRIs. Here is what the research shows:
| Study | Condition | Design | Key Finding | Tag |
|---|---|---|---|---|
| Carhart-Harris et al. 2021 (NEJM) | Treatment-Resistant Depression | RCT vs escitalopram (59 pts) | Equal efficacy to SSRI; psilocybin superior on secondary emotional processing measures | Phase IIb |
| Davis et al. 2021 (JAMA Psychiatry) | Major Depressive Disorder | RCT (24 pts, immediate vs delayed) | Rapid reduction in HAMD-17; effects at 1 week, sustained 4 weeks | Replication |
| Griffiths et al. 2016 (JPC) | Cancer-related anxiety/depression | Double-blind crossover (51 pts) | 80% significant reduction in depression/anxiety; sustained 6 months | Landmark RCT |
| Johnson et al. 2014 (JPC) | Nicotine addiction | Open-label (15 pts) | 80% abstinence at 6-month follow-up; highest published rate for any smoking cessation treatment | Pilot |
| Bogenschutz et al. 2022 (NEJM) | Alcohol Use Disorder | Double-blind RCT (93 pts) | Significant reduction in heavy drinking days vs placebo; clinically meaningful effect sizes | Phase II RCT |
| Rucker et al. 2022 meta-analysis (JPC) | Depression / Anxiety | 13-trial meta-analysis | Large effect sizes (Hedges' g >1.0) for depression; no serious adverse events attributable to psilocybin | Meta-Analysis |
Sources: NEJM 2021; JAMA Psychiatry 2021; JPC 2016, 2022; NEJM 2022. This table is for educational purposes only. Always consult a qualified healthcare provider.
Not a trip.
A visitation.
What psilocybin produces is not a linear narrative. It is better described as a re-organisation of meaning — the psyche presenting its own content with an intensity, beauty, and precision it does not allow in ordinary consciousness. Themes commonly encountered include: grief that was never fully felt, relational patterns held since childhood, the difference between the persona worn for the world and the person underneath it.
Set (mindset before the experience) and setting (the relational and physical container) are not peripheral variables. They are primary. Controlled research environments consistently show superior outcomes when a prepared, trusting therapeutic relationship exists. This is not a supplement. It is a journey that requires a guide.
The neuroscience and the Mazatec tradition agree on one thing: the medicine goes where it is needed. Your role is to prepare the conditions — and then to surrender.
Not guilt.
Discernment.
You do not need shame to engage with this medicine responsibly. Shame is not a compass — it is a contraction. What this medicine asks of you is something more demanding: discernment. The capacity to distinguish between what is yours and what is not. Between containers that are structurally sound and containers that are not. Between preparation and performance.
The fact that your ancestors had their own relationship with visionary states does not exempt you from the responsibility of right engagement with living traditions. It actually asks more of you — because you are someone who comes with roots, not someone who arrives empty. Your European lineage is the beginning of the conversation, not its conclusion. The Mazatec velada, the Sami drum, the Eleusinian chamber — these are not interchangeable, and they are not yours to mix and match. They are models of precision, built over centuries, that deserve study, not sampling.
Right engagement looks specific: choosing guides trained in lineage over weekend certifications; redirecting financial resources toward the communities with the deepest knowledge; refusing to reduce a 3,000-year ceremonial technology to a therapeutic product; bringing your full nervous system — not your spiritual persona — to the door.
Where the knowledge
survived intact.
The European thread was interrupted. What you are returning to today is not a tradition that preserved itself neatly from the Paleolithic to the present — it is a re-encounter. And to re-encounter something well, you need to know what the intact version looks like.
A ceremony three thousand years in the making.
The Mazatec people of Oaxaca never lost the thread. Through colonial suppression, Catholic prohibition, and the criminalization of interior experience — they held it. The velada is their all-night ceremony: darkness, copal smoke, the curandera's voice structuring the psychic space with precision refined across generations.
That sentence is worth holding. The medicine was not seeking you. You were seeking the medicine. The difference determines everything about how you approach it.
The container is becoming legal before the culture has learned how to prepare people to use it safely. That is precisely where Rosa's work lives — in the gap between access and readiness, holding the bridge.
The question is not whether you can access this medicine. The question is whether you can receive what it offers. That is a different question entirely — one that has nothing to do with legality and everything to do with what you are willing to honestly examine before you walk through that door.
Ceremony Waitlist
Psilocybin Ceremonies
Europe · Small Group
Rosa facilitates small-group psilocybin ceremonies within legal jurisdictions in Europe. Containers are trauma-aware, preparation-led, and integration-supported. This is not recreational. Join the waitlist to receive information when dates open.
Ready to prepare
with integrity?
Psilocybin works when the container is clean. Rosa works with individuals and small groups to prepare the nervous system, the intention, and the relational field — and to integrate what emerges.
View Retreats Preparation Program